Faculty Opinions recommendation of [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
作者
Patrick O. Richard
出处
期刊：日期：2021-03-12被引量：3
标识
DOI：10.3410/f.739562946.793583755
摘要
Read the full review for this Faculty Opinions recommended article: [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
cdercder
我能私信骂你吗
Nole
DOC_XIONG
秋风
aaaa
Criminology34
OK
chenc
arniu2008
修仙中
无聊的之槐
v0id
dde
GlenHe
Kao
DW
sagitar
水煮电吹风
皖公网安备34019202002308
